CytRx (Molecular Chaperone Technology) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

CytRx (Molecular Chaperone Technology) General Information

Description

Developer of therapeutics addressing unmet medical needs in the fields of oncology and hematology.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 11726 San Vicente Boulevard
  • Suite 650
  • Los Angeles, CA 90049
  • United States
+1 (310)
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • 11726 San Vicente Boulevard
  • Suite 650
  • Los Angeles, CA 90049
  • United States
+1 (310)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CytRx (Molecular Chaperone Technology) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CytRx (Molecular Chaperone Technology)‘s full profile, request access.

Request a free trial

CytRx (Molecular Chaperone Technology) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CytRx (Molecular Chaperone Technology)‘s full profile, request access.

Request a free trial

CytRx (Molecular Chaperone Technology) FAQs

  • Where is CytRx (Molecular Chaperone Technology) headquartered?

    CytRx (Molecular Chaperone Technology) is headquartered in Los Angeles, CA.

  • What industry is CytRx (Molecular Chaperone Technology) in?

    CytRx (Molecular Chaperone Technology)’s primary industry is Therapeutic Devices.

  • Is CytRx (Molecular Chaperone Technology) a private or public company?

    CytRx (Molecular Chaperone Technology) is a Private company.

  • What is the current valuation of CytRx (Molecular Chaperone Technology)?

    The current valuation of CytRx (Molecular Chaperone Technology) is .

  • What is CytRx (Molecular Chaperone Technology)’s current revenue?

    The current revenue for CytRx (Molecular Chaperone Technology) is .

  • Who are CytRx (Molecular Chaperone Technology)’s investors?

    LadRx has invested in CytRx (Molecular Chaperone Technology).

  • When was CytRx (Molecular Chaperone Technology) acquired?

    CytRx (Molecular Chaperone Technology) was acquired on 17-May-2011.

  • Who acquired CytRx (Molecular Chaperone Technology)?

    CytRx (Molecular Chaperone Technology) was acquired by Strategic Partners (Denmark).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process